EMAIL THIS PAGE TO A FRIEND

IUBMB life

Treg-specific demethylated region activity in isolated regulatory t lymphocytes is a surrogate for disease severity in hepatocellular carcinoma.


PMID 25907075

Abstract

In certain unique conditions like viral infections of the liver like hepatitis B (HBV) and hepatitis C (HCV), activation of Tregs may be associated with chronicity of the viral infections and subsequent predisposition to development of hepatocellular carcinoma (HCC) by the integrated viral genome. In parallel, potential persistence of Tregs activity may lead to immune evasion of cancerous cells and thus persistence of the carcinomatous conditions. In this study, we hypothesized that although the relative proportions of Tregs may remain unaltered in HCC, persistence of activity of Tregs may lead to immune evasion in advanced stages of HCC. To examine the issue of activation of Treg in liver cancer pathogenesis, we obtained liver biopsy and peripheral blood samples from patients with advanced grades of HCC, isolated Tregs, and examined the methylation status of "Treg-specific demethylated region" (TSDR), a key region whose methylation suppresses Treg activity and demethylation stimulates its genomic activity. This study provides evidence of demethylation of TSDR, increased gene expression examined by luciferase assays, and nuclear translocation of key transcription factors that function as gene enhancers in CD4+CD25+FoxP3 regulatory T cells in advanced grades of HCC.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

AV41764
Anti-GNAS (AB1) antibody produced in rabbit, IgG fraction of antiserum
AV41765
Anti-GNAS (AB2) antibody produced in rabbit, IgG fraction of antiserum
AV42694
Anti-GNAS (AB3) antibody produced in rabbit, IgG fraction of antiserum
SAB2501411
Anti-GNAS antibody produced in goat, affinity isolated antibody, buffered aqueous solution
HPA018122
Anti-GNAS antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB2100941
Anti-GNAS antibody produced in rabbit, affinity isolated antibody
HPA027478
Anti-GNAS antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution, ab1
HPA028386
Anti-GNAS antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution, ab2
SAB1400841
Anti-LIPH antibody produced in mouse, IgG fraction of antiserum, buffered aqueous solution
HPA049079
Anti-LIPH antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB2107647
Anti-LIPH antibody produced in rabbit, affinity isolated antibody
HPA021656
Anti-SLC10A3 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB2105728
Anti-SLC10A3 antibody produced in rabbit, affinity isolated antibody